LUMINOPIA, INC.
FDA-cleared binocular vision therapy software for treating amblyopia
- Sector
- Medtech
- Headquarters
- CAMBRIDGE, MA
- Founded
- 2015
- Latest Form D
- $15.8M, Jun 2023
- Total capital
- $36.5M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $36.5M
- 7 Form D · last Jun 2023
- 40 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 1
- 3 pending · first 2024
- Rank in peer group#32 of 122
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 7th filing$15.8M
- Private capital raisedForm D · SEC · 6th filing$4.1M
- Private capital raisedForm D · SEC · 5th filing$11.1M
- Private capital raisedForm D · SEC · 4th filing$1.3M
- Private capital raisedForm D · SEC · 3rd filing$3.6M
- Private capital raisedForm D · SEC · 2nd filing$410K
- Private capital raisedForm D · SEC · 1st filing$250K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 122 peers
Line = medianMedtech · Software
- Granted patents#32 · top 26%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- Dean TraversResearcherDirectorLinked by 1 patent
- ALEXANDER A. WENDLANDExecutive Officer, DirectorNamed in SEC Form D filings
- Casey TanseyDirectorNamed in SEC Form D filings
- Jeffrey DunnDirectorNamed in SEC Form D filings
- Joi ItoDirectorNamed in SEC Form D filings
- MARK A. DOCKSERExecutive OfficerNamed in SEC Form D filings
Show all 11 people
- Mark JacobsteinDirectorNamed in SEC Form D filings
- Michelle LeeDirectorNamed in SEC Form D filings
- Robert LangerDirectorNamed in SEC Form D filings
- Scott XiaoExecutive Officer, DirectorNamed in SEC Form D filings
- William DaiDirectorNamed in SEC Form D filings
What it has protected
USPTO · 1 granted of 4- PendingVisual Disorder TreatmentUSPTOApplication 18805253
- GrantedVisual disorder treatmentUSPTOUS 12,076,495
- PendingMethods And Head-mounted Apparatus For Visual Care And EnhancementUSPTOApplication PCTUS2017027629
Show all 4 patent records
- Visual Disorder TreatmentApr 10, 2025 · Application 18805253Pending
- Visual disorder treatmentSep 3, 2024 · US 12,076,495Granted
- Methods And Head-mounted Apparatus For Visual Care And EnhancementApplication PCTUS2017027629Pending
- Treatment of Visual Disorders and Conditions with Virtual RealityApplication 62323284Pending
Related companies, and why
- Stroma Medical CorpSimilar federal contract value in Medtech · null in contracts
- Ventana Micro Systems Inc.Similar federal contract value in Medtech · null in contracts
- Urotronic, Inc.Similar federal contract value in Medtech · null in contracts
- Rivermark Medical, Inc.Similar federal contract value in Medtech · null in contracts
- Preceptis Medical, Inc.Similar federal contract value in Medtech · null in contracts
- CarePredictSimilar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .